Clinical Trials Browser

OTHER × Breast Neoplasms × Gene Expression Profiling × Clear all

NCT00898508 2025-06-25

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00499083 2023-09-29

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Phase 2 Completed

17 enrolled 5 charts

Breast Neoplasms

NCT00665457 2023-09-13

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Phase 2 Terminated

3 enrolled 6 charts

Breast Neoplasms

NCT01407770 2023-03-28

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Depression, Fatigue, Pain, Radiation Injuries, Skin Abnormalities

NCT00436566 2022-08-05

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Phase 2 Completed

122 enrolled 22 charts

Breast Neoplasms, Breast Neoplasms, Male, Cardiotoxicity

NCT00918892 2022-08-01

Assessment of Candidate Protein Expression in Breast Cancer Specimens

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

Phase NA Completed

8 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01562288 2019-07-02

Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab

Breast Neoplasms

NCT00991263 2017-08-08

Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741

Breast Neoplasms

NCT00764322 2017-08-01

NRR

Phase 2 Completed

501 enrolled 14 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00899197 2017-08-01

Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Breast Neoplasms

NCT00379509 2017-03-21

Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT01293032 2016-07-12

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Phase NA Completed

59 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00898573 2015-10-02

Lapatinib Resistance in Patients With Breast Cancer

Breast Neoplasms

NCT00544804 2014-07-02

Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01138345 2014-02-27

Biomarkers in Blood Samples From Older Breast Cancer Survivors

Breast Neoplasms

NCT00900406 2012-11-06

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Testicular Germ Cell Tumor, Breast Neoplasms, Graft vs Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Gestational Trophoblastic Disease, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases